Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -17.77% is 51% above its 5-year average of -36.18%, near the high end of its 5-year range (-332.72%–1.48%).
2.13% below its 12-month average of -17.40%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 1.48%.
NET PROFIT MARGIN
-17.77%
NET PROFIT MARGIN AVG TTM
-17.40%
NET PROFIT MARGIN AVG 3Y
-26.83%
NET PROFIT MARGIN AVG 5Y
-36.18%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-2.13%
CURRENT VS 3Y AVG
+33.78%
CURRENT VS 5Y AVG
+50.88%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
9.21%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-293.05%
vs the sector median at left
Tempus AI, Inc.
Market Cap
$10.28B
Net Profit Margin
-17.77%
TTM Avg
-17.40%
3Y Avg
-26.83%
5Y Avg
-36.18%
Market Cap
$10.37B
Net Profit Margin
-0.02%
TTM Avg
1.97%
3Y Avg
2.41%
5Y Avg
2.58%
Market Cap
$10.45B
Net Profit Margin
8.42%
TTM Avg
7.89%
3Y Avg
6.46%
5Y Avg
6.98%
Market Cap
$10.07B
Net Profit Margin
6.90%
TTM Avg
6.89%
3Y Avg
6.71%
5Y Avg
6.89%
Market Cap
$9.99B
Net Profit Margin
8.59%
TTM Avg
-21.22%
3Y Avg
-48.94%
5Y Avg
16.61%
Market Cap
$9.97B
Net Profit Margin
17.03%
TTM Avg
11.20%
3Y Avg
12.20%
5Y Avg
12.89%
Market Cap
$9.94B
Net Profit Margin
2.96%
TTM Avg
3.05%
3Y Avg
3.43%
5Y Avg
3.79%
Market Cap
$10.64B
Net Profit Margin
13.46%
TTM Avg
9.62%
3Y Avg
9.77%
5Y Avg
24.94%
Market Cap
$10.71B
Net Profit Margin
9.99%
TTM Avg
10.36%
3Y Avg
10.48%
5Y Avg
22.21%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tempus AI, Inc. (TEM) | $10.28B | -17.77% | -17.40% | -26.83% | -36.18% |
| Molina Healthcare, Inc. (MOH)vs › | $10.37B | -0.02% | 1.97% | 2.41% | 2.58% |
| Universal Health Services, Inc. (UHS)vs › | $10.45B | 8.42% | 7.89% | 6.46% | 6.98% |
| The Ensign Group, Inc. (ENSG)vs › | $10.07B | 6.90% | 6.89% | 6.71% | 6.89% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.99B | 8.59% | -21.22% | -48.94% | 16.61% |
| Globus Medical, Inc. (GMED)vs › | $9.97B | 17.03% | 11.20% | 12.20% | 12.89% |
| Henry Schein, Inc. (HSIC)vs › | $9.94B | 2.96% | 3.05% | 3.43% | 3.79% |
| The Cooper Companies, Inc. (COO)vs › | $10.64B | 13.46% | 9.62% | 9.77% | 24.94% |
| Align Technology, Inc. (ALGN)vs › | $10.71B | 9.99% | 10.36% | 10.48% | 22.21% |
| Insulet Corp. (PODD)vs › | $9.33B | 12.29% | 14.66% | 10.46% | 7.35% |
Operating Margin
-19.8%
Net Profit Margin
-17.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 1.48% |
| 2026-03-31 | -36.17% |
| 2025-12-31 | -14.75% |
| 2025-09-30 | -23.93% |
| 2025-06-30 | -13.62% |
| 2025-03-31 | -26.60% |
| 2024-12-31 | -6.48% |
| 2024-09-30 | -41.92% |
| 2024-06-30 | -332.72% |
| 2024-03-31 | -44.40% |
| 2023-12-31 | -34.17% |
| 2023-09-30 | -39.27% |
| 2023-06-30 | -42.16% |
| 2023-03-31 | -47.03% |
| 2022-12-31 | -65.66% |
| 2022-09-30 | 0.00% |
| 2021-12-31 | -80.45% |
| 2021-09-30 | -130.30% |
| 2021-06-30 | -99.83% |
| 2021-03-31 | -99.83% |
| 2020-12-31 | -53.68% |
| 2020-09-30 | -113.36% |
| 2020-06-30 | -269.64% |
| 2020-03-31 | -269.64% |
